Cognito Therapeutics vs Degron Therapeutics
Cognito Therapeutics vs Degron Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cognito Therapeutics is on 50/100 and Degron Therapeutics on 62/100.
Where each one leads
Cognito Therapeutics
- agent readiness: 33/100 against 27/100
- domain rating: 47/100 against 24/100
- funding raised: $213M against $40.0M
Degron Therapeutics
- our overall score: 62/100 against 50/100
At a glance
| Measure | Cognito Therapeutics | Degron Therapeutics |
|---|---|---|
| What it is | Developing a novel therapeutic approach for Alzheimer's disease. | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. |
| Category | Biotechnology, Medical Devices, Neuroscience, Healthcare | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Hardware | Platform |
| Founded | 2011 | 2020 |
| Headquarters | Boston, USA | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Cognito Therapeutics | Degron Therapeutics |
|---|---|---|
| Employees | Not published | 24 |
| Total funding | $213M | $40.0M |
| Latest round | Series C | Series A Extension |
| Valuation | $487M | $1.1B |
| LinkedIn followers | Not published | 1,380 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cognito Therapeutics | Degron Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 50/100 | 62/100 |
| Traction | 40/100 | Not published |
| Team | 60/100 | 24/100 |
| Search visibility | 10/100 | 57/100 |
| Quality | 65/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (33/100) | F (27/100) |
| Domain ratingLink authority, 0-100 | 47/100 | 24/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cognito Therapeutics | Degron Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | Webflow | Not detected |
| Analytics | Google Tag Manager | Not detected |
| Open source | Yes | No |
Cognito Therapeutics vs Degron Therapeutics: common questions
Which is better, Cognito Therapeutics or Degron Therapeutics?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Cognito Therapeutics and Degron Therapeutics compare on the numbers?
Cognito Therapeutics leads on agent readiness (33/100 against 27/100), domain rating (47/100 against 24/100), funding raised ($213M against $40.0M). Degron Therapeutics leads on our overall score (62/100 against 50/100).
Read the full Cognito Therapeutics review and pricing or the Degron Therapeutics review and pricing. You can also browse other Cognito Therapeutics alternatives we track.